img

Global Drugs of UDCA Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Drugs of UDCA Market Insights, Forecast to 2034

The drug decreases the absorption of cholesterol and is used to dissolve (cholesterol) gallstones in patients as an alternative to a surgical procedure to remove the gallstones.
Global Drugs of UDCA market is expected to reach to US$ 1842 million in 2024, with a positive growth of %, compared with US$ 1645 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Drugs of UDCA industry is evaluated to reach US$ 3389.8 million in 2029. The CAGR will be 10.7% during 2024 to 2029.
UDCA is a bile acid used in the treatment of various liver disorders, such as primary biliary cholangitis and primary sclerosing cholangitis. The increasing prevalence of these liver diseases, along with growing awareness about their diagnosis and treatment, is driving market growth. Additionally, advancements in drug formulations, such as the development of extended-release and combination therapies, are further contributing to market expansion. The market is highly competitive, with several pharmaceutical companies actively engaged in the production and distribution of UDCA drugs. However, challenges such as high drug costs, side effects, and limited accessibility in certain regions may hinder market growth.
Report Covers
This report presents an overview of global Drugs of UDCA market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Drugs of UDCA market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks
Segment by Type
Capsule
Tablet

Segment by Application


Gallstone
Hepatopathy
Biliary Disease
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Drugs of UDCA plant distribution, commercial date of Drugs of UDCA, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Drugs of UDCA introduction, etc. Drugs of UDCA Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Drugs of UDCA
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Drugs of UDCA Product Introduction
1.2 Market by Type
1.2.1 Global Drugs of UDCA Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Capsule
1.2.3 Tablet
1.3 Market by Application
1.3.1 Global Drugs of UDCA Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Gallstone
1.3.3 Hepatopathy
1.3.4 Biliary Disease
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Drugs of UDCA Sales Estimates and Forecasts 2018-2029
2.2 Global Drugs of UDCA Revenue by Region
2.2.1 Global Drugs of UDCA Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Drugs of UDCA Revenue by Region (2018-2024)
2.2.3 Global Drugs of UDCA Revenue by Region (2024-2029)
2.2.4 Global Drugs of UDCA Revenue Market Share by Region (2018-2029)
2.3 Global Drugs of UDCA Sales Estimates and Forecasts 2018-2029
2.4 Global Drugs of UDCA Sales by Region
2.4.1 Global Drugs of UDCA Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Drugs of UDCA Sales by Region (2018-2024)
2.4.3 Global Drugs of UDCA Sales by Region (2024-2029)
2.4.4 Global Drugs of UDCA Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Drugs of UDCA Sales by Manufacturers
3.1.1 Global Drugs of UDCA Sales by Manufacturers (2018-2024)
3.1.2 Global Drugs of UDCA Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drugs of UDCA in 2022
3.2 Global Drugs of UDCA Revenue by Manufacturers
3.2.1 Global Drugs of UDCA Revenue by Manufacturers (2018-2024)
3.2.2 Global Drugs of UDCA Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Drugs of UDCA Revenue in 2022
3.3 Global Key Players of Drugs of UDCA, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Drugs of UDCA Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Drugs of UDCA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Drugs of UDCA, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Drugs of UDCA, Product Offered and Application
3.8 Global Key Manufacturers of Drugs of UDCA, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drugs of UDCA Sales by Type
4.1.1 Global Drugs of UDCA Historical Sales by Type (2018-2024)
4.1.2 Global Drugs of UDCA Forecasted Sales by Type (2024-2029)
4.1.3 Global Drugs of UDCA Sales Market Share by Type (2018-2029)
4.2 Global Drugs of UDCA Revenue by Type
4.2.1 Global Drugs of UDCA Historical Revenue by Type (2018-2024)
4.2.2 Global Drugs of UDCA Forecasted Revenue by Type (2024-2029)
4.2.3 Global Drugs of UDCA Revenue Market Share by Type (2018-2029)
4.3 Global Drugs of UDCA Price by Type
4.3.1 Global Drugs of UDCA Price by Type (2018-2024)
4.3.2 Global Drugs of UDCA Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Drugs of UDCA Sales by Application
5.1.1 Global Drugs of UDCA Historical Sales by Application (2018-2024)
5.1.2 Global Drugs of UDCA Forecasted Sales by Application (2024-2029)
5.1.3 Global Drugs of UDCA Sales Market Share by Application (2018-2029)
5.2 Global Drugs of UDCA Revenue by Application
5.2.1 Global Drugs of UDCA Historical Revenue by Application (2018-2024)
5.2.2 Global Drugs of UDCA Forecasted Revenue by Application (2024-2029)
5.2.3 Global Drugs of UDCA Revenue Market Share by Application (2018-2029)
5.3 Global Drugs of UDCA Price by Application
5.3.1 Global Drugs of UDCA Price by Application (2018-2024)
5.3.2 Global Drugs of UDCA Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Drugs of UDCA Market Size by Type
6.1.1 US & Canada Drugs of UDCA Sales by Type (2018-2029)
6.1.2 US & Canada Drugs of UDCA Revenue by Type (2018-2029)
6.2 US & Canada Drugs of UDCA Market Size by Application
6.2.1 US & Canada Drugs of UDCA Sales by Application (2018-2029)
6.2.2 US & Canada Drugs of UDCA Revenue by Application (2018-2029)
6.3 US & Canada Drugs of UDCA Market Size by Country
6.3.1 US & Canada Drugs of UDCA Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Drugs of UDCA Sales by Country (2018-2029)
6.3.3 US & Canada Drugs of UDCA Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Drugs of UDCA Market Size by Type
7.1.1 Europe Drugs of UDCA Sales by Type (2018-2029)
7.1.2 Europe Drugs of UDCA Revenue by Type (2018-2029)
7.2 Europe Drugs of UDCA Market Size by Application
7.2.1 Europe Drugs of UDCA Sales by Application (2018-2029)
7.2.2 Europe Drugs of UDCA Revenue by Application (2018-2029)
7.3 Europe Drugs of UDCA Market Size by Country
7.3.1 Europe Drugs of UDCA Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Drugs of UDCA Sales by Country (2018-2029)
7.3.3 Europe Drugs of UDCA Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Drugs of UDCA Market Size
8.1.1 China Drugs of UDCA Sales (2018-2029)
8.1.2 China Drugs of UDCA Revenue (2018-2029)
8.2 China Drugs of UDCA Market Size by Application
8.2.1 China Drugs of UDCA Sales by Application (2018-2029)
8.2.2 China Drugs of UDCA Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Drugs of UDCA Market Size by Type
9.1.1 Asia Drugs of UDCA Sales by Type (2018-2029)
9.1.2 Asia Drugs of UDCA Revenue by Type (2018-2029)
9.2 Asia Drugs of UDCA Market Size by Application
9.2.1 Asia Drugs of UDCA Sales by Application (2018-2029)
9.2.2 Asia Drugs of UDCA Revenue by Application (2018-2029)
9.3 Asia Drugs of UDCA Sales by Region
9.3.1 Asia Drugs of UDCA Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Drugs of UDCA Revenue by Region (2018-2029)
9.3.3 Asia Drugs of UDCA Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Drugs of UDCA Market Size by Type
10.1.1 Middle East, Africa and Latin America Drugs of UDCA Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Drugs of UDCA Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Drugs of UDCA Market Size by Application
10.2.1 Middle East, Africa and Latin America Drugs of UDCA Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Drugs of UDCA Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Drugs of UDCA Sales by Country
10.3.1 Middle East, Africa and Latin America Drugs of UDCA Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Drugs of UDCA Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Drugs of UDCA Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Dr. Falk Pharma
11.1.1 Dr. Falk Pharma Company Information
11.1.2 Dr. Falk Pharma Overview
11.1.3 Dr. Falk Pharma Drugs of UDCA Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Dr. Falk Pharma Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Dr. Falk Pharma Recent Developments
11.2 Daewoong Pharmaceutical
11.2.1 Daewoong Pharmaceutical Company Information
11.2.2 Daewoong Pharmaceutical Overview
11.2.3 Daewoong Pharmaceutical Drugs of UDCA Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Daewoong Pharmaceutical Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Daewoong Pharmaceutical Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Drugs of UDCA Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Teva Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Epic Pharma
11.4.1 Epic Pharma Company Information
11.4.2 Epic Pharma Overview
11.4.3 Epic Pharma Drugs of UDCA Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Epic Pharma Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Epic Pharma Recent Developments
11.5 Mitsubishi Tanabe Pharma
11.5.1 Mitsubishi Tanabe Pharma Company Information
11.5.2 Mitsubishi Tanabe Pharma Overview
11.5.3 Mitsubishi Tanabe Pharma Drugs of UDCA Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Mitsubishi Tanabe Pharma Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mitsubishi Tanabe Pharma Recent Developments
11.6 Lannett
11.6.1 Lannett Company Information
11.6.2 Lannett Overview
11.6.3 Lannett Drugs of UDCA Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Lannett Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lannett Recent Developments
11.7 Mylan
11.7.1 Mylan Company Information
11.7.2 Mylan Overview
11.7.3 Mylan Drugs of UDCA Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Mylan Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mylan Recent Developments
11.8 Bruschettini
11.8.1 Bruschettini Company Information
11.8.2 Bruschettini Overview
11.8.3 Bruschettini Drugs of UDCA Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bruschettini Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bruschettini Recent Developments
11.9 Impax
11.9.1 Impax Company Information
11.9.2 Impax Overview
11.9.3 Impax Drugs of UDCA Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Impax Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Impax Recent Developments
11.10 Shanghai Pharma
11.10.1 Shanghai Pharma Company Information
11.10.2 Shanghai Pharma Overview
11.10.3 Shanghai Pharma Drugs of UDCA Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Shanghai Pharma Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shanghai Pharma Recent Developments
11.11 Grindeks
11.11.1 Grindeks Company Information
11.11.2 Grindeks Overview
11.11.3 Grindeks Drugs of UDCA Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Grindeks Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Grindeks Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drugs of UDCA Industry Chain Analysis
12.2 Drugs of UDCA Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drugs of UDCA Production Mode & Process
12.4 Drugs of UDCA Sales and Marketing
12.4.1 Drugs of UDCA Sales Channels
12.4.2 Drugs of UDCA Distributors
12.5 Drugs of UDCA Customers
13 Market Dynamics
13.1 Drugs of UDCA Industry Trends
13.2 Drugs of UDCA Market Drivers
13.3 Drugs of UDCA Market Challenges
13.4 Drugs of UDCA Market Restraints
14 Key Findings in The Global Drugs of UDCA Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Drugs of UDCA Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Tablet
Table 4. Global Drugs of UDCA Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Drugs of UDCA Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Drugs of UDCA Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Drugs of UDCA Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Drugs of UDCA Revenue Market Share by Region (2018-2024)
Table 9. Global Drugs of UDCA Revenue Market Share by Region (2024-2029)
Table 10. Global Drugs of UDCA Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Drugs of UDCA Sales by Region (2018-2024) & (K Units)
Table 12. Global Drugs of UDCA Sales by Region (2024-2029) & (K Units)
Table 13. Global Drugs of UDCA Sales Market Share by Region (2018-2024)
Table 14. Global Drugs of UDCA Sales Market Share by Region (2024-2029)
Table 15. Global Drugs of UDCA Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Drugs of UDCA Sales Share by Manufacturers (2018-2024)
Table 17. Global Drugs of UDCA Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Drugs of UDCA Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Drugs of UDCA, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Drugs of UDCA Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Drugs of UDCA Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Drugs of UDCA by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs of UDCA as of 2022)
Table 23. Global Key Manufacturers of Drugs of UDCA, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Drugs of UDCA, Product Offered and Application
Table 25. Global Key Manufacturers of Drugs of UDCA, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Drugs of UDCA Sales by Type (2018-2024) & (K Units)
Table 28. Global Drugs of UDCA Sales by Type (2024-2029) & (K Units)
Table 29. Global Drugs of UDCA Sales Share by Type (2018-2024)
Table 30. Global Drugs of UDCA Sales Share by Type (2024-2029)
Table 31. Global Drugs of UDCA Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Drugs of UDCA Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Drugs of UDCA Revenue Share by Type (2018-2024)
Table 34. Global Drugs of UDCA Revenue Share by Type (2024-2029)
Table 35. Drugs of UDCA Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Drugs of UDCA Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Drugs of UDCA Sales by Application (2018-2024) & (K Units)
Table 38. Global Drugs of UDCA Sales by Application (2024-2029) & (K Units)
Table 39. Global Drugs of UDCA Sales Share by Application (2018-2024)
Table 40. Global Drugs of UDCA Sales Share by Application (2024-2029)
Table 41. Global Drugs of UDCA Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Drugs of UDCA Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Drugs of UDCA Revenue Share by Application (2018-2024)
Table 44. Global Drugs of UDCA Revenue Share by Application (2024-2029)
Table 45. Drugs of UDCA Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Drugs of UDCA Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Drugs of UDCA Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Drugs of UDCA Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Drugs of UDCA Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Drugs of UDCA Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Drugs of UDCA Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Drugs of UDCA Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Drugs of UDCA Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Drugs of UDCA Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Drugs of UDCA Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Drugs of UDCA Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Drugs of UDCA Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Drugs of UDCA Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Drugs of UDCA Sales by Country (2024-2029) & (K Units)
Table 60. Europe Drugs of UDCA Sales by Type (2018-2024) & (K Units)
Table 61. Europe Drugs of UDCA Sales by Type (2024-2029) & (K Units)
Table 62. Europe Drugs of UDCA Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Drugs of UDCA Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Drugs of UDCA Sales by Application (2018-2024) & (K Units)
Table 65. Europe Drugs of UDCA Sales by Application (2024-2029) & (K Units)
Table 66. Europe Drugs of UDCA Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Drugs of UDCA Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Drugs of UDCA Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Drugs of UDCA Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Drugs of UDCA Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Drugs of UDCA Sales by Country (2018-2024) & (K Units)
Table 72. Europe Drugs of UDCA Sales by Country (2024-2029) & (K Units)
Table 73. China Drugs of UDCA Sales by Type (2018-2024) & (K Units)
Table 74. China Drugs of UDCA Sales by Type (2024-2029) & (K Units)
Table 75. China Drugs of UDCA Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Drugs of UDCA Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Drugs of UDCA Sales by Application (2018-2024) & (K Units)
Table 78. China Drugs of UDCA Sales by Application (2024-2029) & (K Units)
Table 79. China Drugs of UDCA Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Drugs of UDCA Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Drugs of UDCA Sales by Type (2018-2024) & (K Units)
Table 82. Asia Drugs of UDCA Sales by Type (2024-2029) & (K Units)
Table 83. Asia Drugs of UDCA Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Drugs of UDCA Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Drugs of UDCA Sales by Application (2018-2024) & (K Units)
Table 86. Asia Drugs of UDCA Sales by Application (2024-2029) & (K Units)
Table 87. Asia Drugs of UDCA Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Drugs of UDCA Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Drugs of UDCA Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Drugs of UDCA Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Drugs of UDCA Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Drugs of UDCA Sales by Region (2018-2024) & (K Units)
Table 93. Asia Drugs of UDCA Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Drugs of UDCA Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Drugs of UDCA Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Drugs of UDCA Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Drugs of UDCA Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Drugs of UDCA Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Drugs of UDCA Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Drugs of UDCA Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Drugs of UDCA Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Drugs of UDCA Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Drugs of UDCA Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Drugs of UDCA Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Drugs of UDCA Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Drugs of UDCA Sales by Country (2024-2029) & (K Units)
Table 107. Dr. Falk Pharma Company Information
Table 108. Dr. Falk Pharma Description and Major Businesses
Table 109. Dr. Falk Pharma Drugs of UDCA Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Dr. Falk Pharma Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Dr. Falk Pharma Recent Developments
Table 112. Daewoong Pharmaceutical Company Information
Table 113. Daewoong Pharmaceutical Description and Major Businesses
Table 114. Daewoong Pharmaceutical Drugs of UDCA Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Daewoong Pharmaceutical Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Daewoong Pharmaceutical Recent Developments
Table 117. Teva Company Information
Table 118. Teva Description and Major Businesses
Table 119. Teva Drugs of UDCA Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Teva Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Teva Recent Developments
Table 122. Epic Pharma Company Information
Table 123. Epic Pharma Description and Major Businesses
Table 124. Epic Pharma Drugs of UDCA Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Epic Pharma Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Epic Pharma Recent Developments
Table 127. Mitsubishi Tanabe Pharma Company Information
Table 128. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 129. Mitsubishi Tanabe Pharma Drugs of UDCA Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Mitsubishi Tanabe Pharma Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Mitsubishi Tanabe Pharma Recent Developments
Table 132. Lannett Company Information
Table 133. Lannett Description and Major Businesses
Table 134. Lannett Drugs of UDCA Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Lannett Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Lannett Recent Developments
Table 137. Mylan Company Information
Table 138. Mylan Description and Major Businesses
Table 139. Mylan Drugs of UDCA Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Mylan Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Mylan Recent Developments
Table 142. Bruschettini Company Information
Table 143. Bruschettini Description and Major Businesses
Table 144. Bruschettini Drugs of UDCA Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Bruschettini Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Bruschettini Recent Developments
Table 147. Impax Company Information
Table 148. Impax Description and Major Businesses
Table 149. Impax Drugs of UDCA Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Impax Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Impax Recent Developments
Table 152. Shanghai Pharma Company Information
Table 153. Shanghai Pharma Description and Major Businesses
Table 154. Shanghai Pharma Drugs of UDCA Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Shanghai Pharma Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Shanghai Pharma Recent Developments
Table 157. Grindeks Company Information
Table 158. Grindeks Description and Major Businesses
Table 159. Grindeks Drugs of UDCA Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. Grindeks Drugs of UDCA Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Grindeks Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Drugs of UDCA Distributors List
Table 165. Drugs of UDCA Customers List
Table 166. Drugs of UDCA Market Trends
Table 167. Drugs of UDCA Market Drivers
Table 168. Drugs of UDCA Market Challenges
Table 169. Drugs of UDCA Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs of UDCA Product Picture
Figure 2. Global Drugs of UDCA Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Drugs of UDCA Market Share by Type in 2022 & 2029
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Global Drugs of UDCA Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Drugs of UDCA Market Share by Application in 2022 & 2029
Figure 8. Gallstone
Figure 9. Hepatopathy
Figure 10. Biliary Disease
Figure 11. Other
Figure 12. Drugs of UDCA Report Years Considered
Figure 13. Global Drugs of UDCA Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Drugs of UDCA Revenue 2018-2029 (US$ Million)
Figure 15. Global Drugs of UDCA Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Drugs of UDCA Revenue Market Share by Region (2018-2029)
Figure 17. Global Drugs of UDCA Sales 2018-2029 ((K Units)
Figure 18. Global Drugs of UDCA Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Drugs of UDCA Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Drugs of UDCA Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Drugs of UDCA Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Drugs of UDCA Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Drugs of UDCA Sales YoY (2018-2029) & (K Units)
Figure 24. China Drugs of UDCA Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Drugs of UDCA Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Drugs of UDCA Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Drugs of UDCA Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Drugs of UDCA Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Drugs of UDCA Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Drugs of UDCA in the World: Market Share by Drugs of UDCA Revenue in 2022
Figure 31. Global Drugs of UDCA Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Drugs of UDCA Sales Market Share by Type (2018-2029)
Figure 33. Global Drugs of UDCA Revenue Market Share by Type (2018-2029)
Figure 34. Global Drugs of UDCA Sales Market Share by Application (2018-2029)
Figure 35. Global Drugs of UDCA Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Drugs of UDCA Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Drugs of UDCA Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Drugs of UDCA Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Drugs of UDCA Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Drugs of UDCA Revenue Share by Country (2018-2029)
Figure 41. US & Canada Drugs of UDCA Sales Share by Country (2018-2029)
Figure 42. U.S. Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Drugs of UDCA Sales Market Share by Type (2018-2029)
Figure 45. Europe Drugs of UDCA Revenue Market Share by Type (2018-2029)
Figure 46. Europe Drugs of UDCA Sales Market Share by Application (2018-2029)
Figure 47. Europe Drugs of UDCA Revenue Market Share by Application (2018-2029)
Figure 48. Europe Drugs of UDCA Revenue Share by Country (2018-2029)
Figure 49. Europe Drugs of UDCA Sales Share by Country (2018-2029)
Figure 50. Germany Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 51. France Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 52. UK Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 55. China Drugs of UDCA Sales Market Share by Type (2018-2029)
Figure 56. China Drugs of UDCA Revenue Market Share by Type (2018-2029)
Figure 57. China Drugs of UDCA Sales Market Share by Application (2018-2029)
Figure 58. China Drugs of UDCA Revenue Market Share by Application (2018-2029)
Figure 59. Asia Drugs of UDCA Sales Market Share by Type (2018-2029)
Figure 60. Asia Drugs of UDCA Revenue Market Share by Type (2018-2029)
Figure 61. Asia Drugs of UDCA Sales Market Share by Application (2018-2029)
Figure 62. Asia Drugs of UDCA Revenue Market Share by Application (2018-2029)
Figure 63. Asia Drugs of UDCA Revenue Share by Region (2018-2029)
Figure 64. Asia Drugs of UDCA Sales Share by Region (2018-2029)
Figure 65. Japan Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 69. India Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Drugs of UDCA Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Drugs of UDCA Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Drugs of UDCA Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Drugs of UDCA Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Drugs of UDCA Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Drugs of UDCA Sales Share by Country (2018-2029)
Figure 76. Brazil Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Drugs of UDCA Revenue (2018-2029) & (US$ Million)
Figure 81. Drugs of UDCA Value Chain
Figure 82. Drugs of UDCA Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries